Whilst GLP-1 medications such as semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda) do not directly target reproductive hormones, the substantial weight loss and metabolic changes they produce can indirectly influence period regularity
You simply can't conduct credible science with compromised materials
The Illumineuro blend is a four-peptide research blend containing N-Acetyl Semax (20mg), N-Acetyl Selank (10mg), Pinealon (10mg), and PE-22-28 (10mg) in a single 50mg lyophilized vial
Because its administered intravenously, the nutrients bypass the digestive system, allowing for higher concentrations to reach the cells quickly and efficiently
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Ozempic, Rybelsus) and chronic weight management (Wegovy) in adults, with Wegovy also approved for adolescents 12 years and older with obesity